SCHEMBL191509

SCHEMBL191509

CCCCCCCCCCCCCCCCOc1ccccc1.[NaH].[NaH]

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.78
KCNA3 P22001 1/20 0.70
MLNR O43193 1/20 0.66
NR1I2 O75469 1/20 0.66
ESR1 P03372 1/20 0.66
NR3C1 P04150 1/20 0.66
PGR P06401 1/20 0.66
ADRB2 P07550 1/20 0.66
CHRM2 P08172 1/20 0.66
ADRB1 P08588 1/20 0.66
HTR1A P08908 1/20 0.66
ADRA2A P08913 1/20 0.66
ADORA3 P0DMS8 1/20 0.66
CHRM1 P11229 1/20 0.66
DRD2 P14416 1/20 0.66
ADRA2B P18089 1/20 0.66
ADRA2C P18825 1/20 0.66
CHRM3 P20309 1/20 0.66
MAOA P21397 1/20 0.66
CNR1 P21554 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190814 1.00 LTA4H (0.78) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL27673298 1.00 LTA4H (0.78) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL22032627 1.00 LTA4H (0.78) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL27916331 1.00 LTA4H (0.78) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL27531446 1.00 LTA4H (0.78) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL192256 1.00 LTA4H (0.78) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL25193869 1.00 LTA4H (0.78) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL4631521 0.98 LTA4H (0.81) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL9342022 0.98 LTA4H (0.81) LTA4HKCNA3MLNRNR1I2ESR1
SCHEMBL325289 0.98 LTA4H (0.81) LTA4HKCNA3MLNRNR1I2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645017-A1 COMPOSITIONS, METHODS AND USES FOR CLEANING, DISINFECTING AND/OR STERILIZING Collidion, Inc. (US) 2020-05-06 EP claimed
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 US claimed
WO-2019006217-A1 COMPOSITIONS, METHODS AND USES FOR CLEANING, DISINFECTING AND/OR STERILIZING Collidion, Inc. (US) 2019-01-03 WO claimed
US-20240237643-A1 COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY SYMRISE AG (DE) 2024-07-18 US disclosed
US-20240216248-A1 MICROBIAL GLYCOLIPIDS ANALYTICON DISCOVERY GMBH (DE) 2024-07-04 US disclosed
EP-4387587-A1 COMPOSITIONS Symrise AG (DE) 2024-06-26 EP disclosed
US-12010992-B2 Dry powdered compositions and methods and uses thereof NEOZYME INTERNATIONAL, INC. (US) 2024-06-18 US disclosed
US-20240173227-A1 A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL SYMRISE AG (DE) 2024-05-30 US disclosed
WO-2024110515-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2024-05-30 WO disclosed
WO-2024110023-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2024-05-30 WO disclosed
WO-2024104625-A1 A BLEND OF EMOLLIENTS SYMRISE AG (DE) 2024-05-23 WO disclosed
EP-1317522-A1 QUICK DRYING WASHING AND CLEANING AGENT, ESPECIALLY WASHING-UP LIQUID Henkel Kommanditgesellschaft auf Aktien (DE) 2003-06-11 EP disclosed
WO-2003009819-A2 TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS DOW CORNING CORPORATION (US) 2003-02-06 WO disclosed
US-6498197-B1 Temperature insensitive one-phase microemulsions DOW CORNING CORPORATION 2002-12-24 US disclosed
EP-1256336-A2 Two-phase gel composition Penreco (US) 2002-11-13 EP disclosed
US-20020055562-A1 Gel compositions WILMINGTON TRUST, NATIONAL ASSOCIATION 2002-05-09 US disclosed
WO-2002022770-A1 QUICK DRYING WASHING AND CLEANING AGENT, ESPECIALLY WASHING-UP LIQUID HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2002-03-21 WO disclosed
US-20010031712-A1 Surfactant Combination HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA (DE) 2001-10-18 US disclosed
EP-1141111-A1 GEL COMPOSITIONS Penreco (US) 2001-10-10 EP disclosed
WO-2000026285-A1 GEL COMPOSITIONS PENRECO (US) 2000-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH LTA4H 301/4885KCNA3 667/4885MLNR 4737/4885
US-20240216248-A1 MICROBIAL GLYCOLIPIDS UGCG, SGMS1, GPR119 LTA4H 603/4885KCNA3 2380/4885MLNR 2907/4885
US-20240237643-A1 COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY ZC3HAV1, SAMHD1, ZC3HAV1L LTA4H 309/4885KCNA3 3026/4885MLNR 4591/4885
US-20240173227-A1 A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL IPO5, OR51E2, FDFT1 LTA4H 504/4885KCNA3 1373/4885MLNR 4437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.